[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351340-105":59,"doc-detail-351340-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","a-signature-agnostic-test-for-differences-between-tumor-mutation-spectra-reveals-carcinogen-and-ancestry-effects","A signature-agnostic test for differences between tumor mutation spectra reveals carcinogen and ancestry effects","","A signature-agnostic metric is presented to rigorously test whether mutational exposures differ between heterogeneous tumor groups, addressing limitations of standard mutational signature analysis. The aggregate mutation spectrum distance permutation method (AMSD) is used to reanalyze mouse carcinogen exposure, identifying significant mutation spectrum shifts for most tested carcinogens. AMSD then detects ancestry-associated differences across ten human cancer types, highlighting both previously known and novel ancestry effects, and supporting discovery of environmental and genetic drivers of mutagenesis.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-signature-agnostic-test-for-differences-between-tumor-mutation-spectra-reveals-carcinogen-and-ancestry-effects/351340/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-signature-agnostic-test-for-differences-between-tumor-mutation-spectra-reveals-carcinogen-and-ancestry-effects/351340.png","ImageObject",300,407,{"name":92,"@type":93},"\tCallum ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does the paper address in comparing tumor mutation spectra?","Question",{"text":113,"@type":114},"It addresses the lack of an established metric for quantifying whether signature exposures differ significantly between two heterogeneous sample groups.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does AMSD work and what does it measure?",{"text":118,"@type":114},"AMSD, the aggregate mutation spectrum distance permutation method, compares mutational exposures between groups using distances in mutation spectra with permutation-based significance.",{"name":120,"@type":111,"acceptedAnswer":121},"What findings emerge from the mouse carcinogen analysis and the human ancestry analysis?",{"text":122,"@type":114},"Reanalysis shows most tested carcinogens produce significant mutation spectrum shifts, including many not previously linked to distinct mutational signatures. For humans, significant ancestry-associated differences are observed across ten cancer types, including both reported and newly observed signature changes.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},351340,1790162243,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137451211410,"https://ap-avatar.wpscdn.com/avatar/2000bb0a9246f588df?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786362646172706240","communications biology Article  \n\n| A Nature Portfolio journal |  | |\n| --- | --- | --- |\n| [https://doi.org/10.1038/s42003-026-09652-5](https://doi.org/10.1038/s42003-026-09652-5) |  |  |\n| A signature-agnostic test for differences between tumor mutation spectra reveals carcinogen and ancestry effects\u003Cbr> Check for updates |  |  |\n| Samuel F. M. Hart  1, Nicolas Alcala 2, Alison F. Feder  1,3,4,5  & Kelley Harris  1,3,5  |  |  |\n| Despite dozens of tools to identify mutational signatures in cancer samples, there isnot an established metric for quantifying whether signature exposures differ signiﬁcantly between two heterogeneous groups of samples. We demonstrate that a signature-agnostic metric-the aggregate mutation spectrum distance permutation method (AMSD) -can rigorously determine whether mutational exposures differ between groups, a hypothesis that is not directly addressed by signature analysis. First, we reanalyze a study of carcinogen exposure in mice, determining that eleven of twenty tested carcinogens produce signiﬁcant mutation spectrum shifts. Only three of these carcinogens were previously reported to induce distinct mutational signatures, suggesting that many carcinogens perturb mutagenesis by altering the composition of endogenous signatures. Next, we interrogate whether patient ancestry has a measurable impact on human tumor mutation spectra, ﬁnding signiﬁcant ancestry-associated differences across ten cancer types. Some have been previously reported, such as elevated SBS4 in African lung adenocarcinomas, while some have not to our knowledge been reported, such as elevated SBS17a/b in European esophageal carcinomas. These examples suggest that AMSD is a robust tool for detecting differences among groups of tumors or other mutated samples, complementing descriptive signature deconvolution and enabling the discovery of environmental and genetic inﬂuences on mutagenesis. |  |  |\n| Mutation ratesand biases in mutational sequence context can beinﬂuenced by endogenous cellular processes, environmental exposures, and genetic variation. All such mutagenic processes can leave decodable imprintson the relative frequency distribution of different possible mutation types in a genome, termed the mutation spectrum, which can be especially complex in the context of cancers. To interpret this variation, a framework has been introduced for jointly decomposing the mutation spectra of thousands of tumors across dozens of cancer types to identify mutational signatures: characteristic mutation type distributions that are thought to reﬂect underlying mutational processes1–3.\u003Cbr>Over 100 mutational signatures are currently listed in the COSMIC database (Catalogue Of Somatic Mutations In Cancer), with the majority being single base substitution (SBS) signatures, which capture the frequencies of nucleotide changes classiﬁed by their 3mer ﬂanking nucleotide context (e.g. CCG > CTG)4. It is now common practice when analyzing cancer genome sequencing data to infer which mutational signatures are | active in a given sample, often revealing key information about each individual cancer’s oncogenesis and evolutionary history.\u003Cbr>While mutational signature analysis is effective for identifying why two mutation spectra may differ, it is not ideal for testing whether or not two spectra differ signiﬁcantly from one another. For a simple comparison between two tumors, a hypergeometric test5 can be used to judge whether they have signiﬁcantly different mutation spectra or mutational signature exposures, but more complex approaches are needed to make sense of exposure distributions in larger datasets that can contain thousands of tumors from patients who differ in various ways that might affect mutagenesis. Mutational signature decomposition offers no formal statistical framework for determining which exposures or characteristics are associated with signiﬁcant differences in tumor mutation proﬁles. When withingroup heterogeneity and between-group ","cbCain8L1JUBLTgW","https://ap.wps.com/l/cbCain8L1JUBLTgW","pdf",1640068,"English","# Introduction\n# AMSD method for group comparisons\n# Mouse carcinogen reanalysis\n# Human ancestry-associated differences\n# Figure 1: Within- vs between-cohort heterogeneity","[{\"question\":\"What problem does the paper address in comparing tumor mutation spectra?\",\"answer\":\"It addresses the lack of an established metric for quantifying whether signature exposures differ significantly between two heterogeneous sample groups.\"},{\"question\":\"How does AMSD work and what does it measure?\",\"answer\":\"AMSD, the aggregate mutation spectrum distance permutation method, compares mutational exposures between groups using distances in mutation spectra with permutation-based significance.\"},{\"question\":\"What findings emerge from the mouse carcinogen analysis and the human ancestry analysis?\",\"answer\":\"Reanalysis shows most tested carcinogens produce significant mutation spectrum shifts, including many not previously linked to distinct mutational signatures. For humans, significant ancestry-associated differences are observed across ten cancer types, including both reported and newly observed signature changes.\"}]","A signature-agnostic test for differences between tumor mutation spectra reveals carcinogen and ancestry effects | PDF",1790093603,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5dde62be9264e3f97566c24e4fe09fae.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b29d795612ffc9b5a4f1d2e9238a69cf.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65425efb172dafb1a28682ca38aa4fed.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e22de435bc0722e318962ce83701dba6.webp",980,1301]